Lv1
60 积分 2024-06-18 加入
Novel immune checkpoint targets: A promising therapy for cancer treatments
13小时前
已完结
Current treatment landscape for patients with non–small cell lung cancer with common EGFR mutations
6天前
已完结
Targeting immune hubs to advance cancer immunotherapy
14天前
已完结
Next-generation combination approaches for immune checkpoint therapy
14天前
已完结
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
16天前
已完结
Non‐Allergic Urticarial Skin Reactions Associated With MOv18 IgE, a First‐In‐Class IgE Antibody Recognising Folate Receptor Alpha
1个月前
已完结
Nectin-4 Expression Patterns and Therapeutics in Oncology
1个月前
已完结
A Molecular Inquiry into the Role of Antibody-Drug Conjugates in Bacillus Calmette-Guérin-exposed Non–muscle-invasive Bladder Cancer
1个月前
已完结
Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay
2个月前
已完结
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
2个月前
已完结
皖公网安备34019202002308
